跳至主要内容
临床试验/NCT04217031
NCT04217031已完成不适用

Decision Variability Between Different Heart Teams for Complex Coronary Artery

China National Center for Cardiovascular Diseases1 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2020年1月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
101
试验地点
1
主要终点
Kappa value of decisions

研究概览

简要总结

The purposes of this study are 1) to explore the variability of decisions between different heart teams in complex coronary artery disease; 2) to evaluate the reasons of the discrepancy in decision making.

详细描述

Heart team has been recommended by guideline for optimizing the decision making for patients with complex coronary artery diseases (CAD). However, prior studies have demonstrated that heart team decision might have poor reproducibility, and the variability of heart team decision remains unknown.

Thus, the investigators designed a single-center, retrospective, cross-sectional study to explore the decision variability of heart team in CAD patients. The investigators will retrospectively recruit patients with angiographically confirmed 3-vessel or left main disease from a coronary angiography database at Fuwai hospital. Patients' baseline information will be collected. And different heart teams will be established and made decisions for the enrolled patients. First, the investigators will assess the decision variability between different heart teams. Secondary, the investigators will evaluate the reason of discrepancy by qualitative and quantitative analysis.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with angiographically confirmed 3-vessel disease or left main disease

排除标准

  • Prior percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG)
  • Myocardial infarction with acute phase judged by Electrocardiograph or biomarkers
  • Combined with severe valvular disease, great vessel disease or huge ventricular aneurysm which need surgery
  • Combined with atrial fibrillation or severe arrhythmia

结局指标

主要结局

Kappa value of decisions

时间窗: at the end of enrollment (6 months)

Kappa value of decisions between different heart teams

次要结局

  • Concordance rate of decisions(at the end of enrollment (6 months))

研究者

发起方
China National Center for Cardiovascular Diseases
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验